An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease

Mira R. Olson, Kevin S. Grewal, Adam Bingaman, Radi Zaki, Shelby Stewart, John Horton, Victor Araya, Jorge Ortiz

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: Hepatitis C is one of the leading causes of death from liver disease in the United States, and is frequently associated with renal disease. Two major organizations - the American Association for the Study of Liver Disease and the National Kidney Foundation - have published recommendations regarding the treatment of hepatitis C in the presence of chronic kidney disease; however, these guidelines do not always provide the same recommendations. Given the paucity of data on adherence to the current guidelines, a survey was conducted to provide information about the current practices of physicians in comparison to the published guidelines. Materials and Methods: An observational studywas conducted via a global survey asking physicians treating patientswho had concurrent hepatitis C and chronic kidney disease. Results: The 218 questionnaires collected requested the physician's subspecialty, the number of transplants performed at the hospital, the usual method of screening for hepatitis C, the preferred route, the indication and frequency of liver biopsy, the use of ribavirin and interferon, the use of hepatitis-C-positive donors in kidney transplant, and consent requirements. Conclusions: Our results showed that many physicians do not follow current recommendations. We argue that a consensus group be formed to set forth guidelines for themanagement of hepatitis C to optimize outcomes, and improve overall morbidity.

Original languageEnglish (US)
Pages (from-to)203-213
Number of pages11
JournalExperimental and Clinical Transplantation
Volume7
Issue number4
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Hepatitis C
Chronic Kidney Failure
Guidelines
Physicians
Chronic Renal Insufficiency
Kidney
Liver Diseases
Therapeutics
Transplants
Ribavirin
Interferons
Surveys and Questionnaires
Cause of Death
Tissue Donors
Organizations
Morbidity
Biopsy
Liver

Keywords

  • Dialysis
  • Interferon
  • Ribavirin
  • Transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease. / Olson, Mira R.; Grewal, Kevin S.; Bingaman, Adam; Zaki, Radi; Stewart, Shelby; Horton, John; Araya, Victor; Ortiz, Jorge.

In: Experimental and Clinical Transplantation, Vol. 7, No. 4, 01.12.2009, p. 203-213.

Research output: Contribution to journalArticle

Olson, Mira R. ; Grewal, Kevin S. ; Bingaman, Adam ; Zaki, Radi ; Stewart, Shelby ; Horton, John ; Araya, Victor ; Ortiz, Jorge. / An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease. In: Experimental and Clinical Transplantation. 2009 ; Vol. 7, No. 4. pp. 203-213.
@article{998f2e22e50c492cb1bfff3f640fb22d,
title = "An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease",
abstract = "Objectives: Hepatitis C is one of the leading causes of death from liver disease in the United States, and is frequently associated with renal disease. Two major organizations - the American Association for the Study of Liver Disease and the National Kidney Foundation - have published recommendations regarding the treatment of hepatitis C in the presence of chronic kidney disease; however, these guidelines do not always provide the same recommendations. Given the paucity of data on adherence to the current guidelines, a survey was conducted to provide information about the current practices of physicians in comparison to the published guidelines. Materials and Methods: An observational studywas conducted via a global survey asking physicians treating patientswho had concurrent hepatitis C and chronic kidney disease. Results: The 218 questionnaires collected requested the physician's subspecialty, the number of transplants performed at the hospital, the usual method of screening for hepatitis C, the preferred route, the indication and frequency of liver biopsy, the use of ribavirin and interferon, the use of hepatitis-C-positive donors in kidney transplant, and consent requirements. Conclusions: Our results showed that many physicians do not follow current recommendations. We argue that a consensus group be formed to set forth guidelines for themanagement of hepatitis C to optimize outcomes, and improve overall morbidity.",
keywords = "Dialysis, Interferon, Ribavirin, Transplantation",
author = "Olson, {Mira R.} and Grewal, {Kevin S.} and Adam Bingaman and Radi Zaki and Shelby Stewart and John Horton and Victor Araya and Jorge Ortiz",
year = "2009",
month = "12",
day = "1",
language = "English (US)",
volume = "7",
pages = "203--213",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
number = "4",

}

TY - JOUR

T1 - An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease

AU - Olson, Mira R.

AU - Grewal, Kevin S.

AU - Bingaman, Adam

AU - Zaki, Radi

AU - Stewart, Shelby

AU - Horton, John

AU - Araya, Victor

AU - Ortiz, Jorge

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Objectives: Hepatitis C is one of the leading causes of death from liver disease in the United States, and is frequently associated with renal disease. Two major organizations - the American Association for the Study of Liver Disease and the National Kidney Foundation - have published recommendations regarding the treatment of hepatitis C in the presence of chronic kidney disease; however, these guidelines do not always provide the same recommendations. Given the paucity of data on adherence to the current guidelines, a survey was conducted to provide information about the current practices of physicians in comparison to the published guidelines. Materials and Methods: An observational studywas conducted via a global survey asking physicians treating patientswho had concurrent hepatitis C and chronic kidney disease. Results: The 218 questionnaires collected requested the physician's subspecialty, the number of transplants performed at the hospital, the usual method of screening for hepatitis C, the preferred route, the indication and frequency of liver biopsy, the use of ribavirin and interferon, the use of hepatitis-C-positive donors in kidney transplant, and consent requirements. Conclusions: Our results showed that many physicians do not follow current recommendations. We argue that a consensus group be formed to set forth guidelines for themanagement of hepatitis C to optimize outcomes, and improve overall morbidity.

AB - Objectives: Hepatitis C is one of the leading causes of death from liver disease in the United States, and is frequently associated with renal disease. Two major organizations - the American Association for the Study of Liver Disease and the National Kidney Foundation - have published recommendations regarding the treatment of hepatitis C in the presence of chronic kidney disease; however, these guidelines do not always provide the same recommendations. Given the paucity of data on adherence to the current guidelines, a survey was conducted to provide information about the current practices of physicians in comparison to the published guidelines. Materials and Methods: An observational studywas conducted via a global survey asking physicians treating patientswho had concurrent hepatitis C and chronic kidney disease. Results: The 218 questionnaires collected requested the physician's subspecialty, the number of transplants performed at the hospital, the usual method of screening for hepatitis C, the preferred route, the indication and frequency of liver biopsy, the use of ribavirin and interferon, the use of hepatitis-C-positive donors in kidney transplant, and consent requirements. Conclusions: Our results showed that many physicians do not follow current recommendations. We argue that a consensus group be formed to set forth guidelines for themanagement of hepatitis C to optimize outcomes, and improve overall morbidity.

KW - Dialysis

KW - Interferon

KW - Ribavirin

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=75649117860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649117860&partnerID=8YFLogxK

M3 - Article

C2 - 20353368

AN - SCOPUS:75649117860

VL - 7

SP - 203

EP - 213

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

IS - 4

ER -